SRPT
Sarepta Therapeutics Inc
18.20$
-2.3%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | -512.4% | – | – | – | – | |
| – | +42.2% | +6.9% | +44.2% | +51.3% | +100.1% | +9.8% | +41.3% | +10.1% | +6.1% | -15.0% | +18.0% | |
| – | +57.9% | -6.7% | +1.7% | +64.5% | +56.8% | +37.5% | +5.4% | +104.5% | -21.7% | +1.0% | -33.0% | |
| – | +40.5% | -6.3% | -397.5% | – | +257.8% | -35.0% | -82.2% | +1,087.9% | – | – | – | |
| – | – | -149.3% | – | – | – | – | -117.7% | – | – | – | – | |
| – | -82.0% | +42.1% | +209.0% | +203.3% | -7.3% | +37.9% | -53.2% | -16.2% | +170.8% | +68.2% | -30.6% | |
| – | – | -1,172.4% | +98.3% | +107.2% | – | -142.5% | – | -311.3% | -84.2% | – | -90.8% | |
| – | – | – | – | – | – | +19.0% | – | – | – | – | – | |
| – | +25.5% | +178.9% | -3.0% | +59.2% | -100.8% | +10.6% | +61.8% | – | – | – | – | |
| – | – | -144.7% | – | -100.6% | – | +18.9% | +4.5% | +0.0% | -100.0% | – | +239,000.0% | |
| – | +41.9% | +155.8% | +134.9% | -40.3% | +21.2% | +6.2% | -17.7% | -58.6% | -46.2% | -0.2% | -234.9% | |
| – | – | +523.7% | +1,033.2% | -148.0% | – | +41.3% | -8.1% | -285.7% | – | – | -145.1% | |
| – | – | – | – | – | – | – | -2,006.5% | – | – | – | – |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.